HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA

Clinical trials for HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA trials appear

Sign up with your email to follow new studies for HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for HTLV-1: drug combo trial targets virus and symptoms

Disease control Not yet recruiting

This study tests whether the drug dolutegravir, alone or with tenofovir, can lower the amount of HTLV-1 virus in the blood and improve symptoms like pain, stiffness, and muscle weakness. About 146 adults with HTLV-1 infection and related health problems will take part. The goal i…

Matched conditions: HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA

Phase: PHASE2 • Sponsor: Carlos Brites • Aim: Disease control

Last updated May 05, 2026 11:56 UTC

HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA

Get alerted when new HTLV I ASSOCIATED T CELL LEUKEMIA LYMPHOMA trials appear

New hope for HTLV-1: drug combo trial targets virus and symptoms